Categoria: Ricerca (pagina 1 di 2)

Low-Dose-Medicine Omeopatia-Omotossicologia Le-prove-scientifiche

Scarica il pdf del volume completo, ottava edizione – riveduta ed aggiornata (circa 8 Mb)

Il trattamento con citochine a basso dosaggio riduce le lesioni da stress ossidativo nei cheratinociti perilesionali da pazienti affetti da vitiligine

Scarica l’abstract: Torello Lotti_Vitiligine_2

VITILIGINE: EFFICACIA DELLA TERAPIA COMBINATA “LOW DOSE CYTOKINES E DIFFERENTI TRATTAMENTI TOPICI”

Scarica l’abstract: Torello Lotti_Vitiligine

PSORIASI: EFFICACIA DEL TRATTAMENTO DELLA PSORIASI CON FOTOTERAPIA E CITOCHINE A BASSO DOSAGGIO

Scarica l’abstract: Torello Lotti_Psoriasi

TRATTAMENTO ORALE DELLA CORIORETINOPATIA SIEROSA CENTRALE CON MEDICINALI LOW-DOSE: STUDIO OSSERVAZIONALE MONOCENTRICO RETROSPETTIVO

Scarica: Abstract_Andrea Basile

Five Years of Low Dose Medicine Research. Review of Preclinical and Clinical Studies with Low Dose SKA Cytokines since 2009

Five Years of Low Dose Medicine Research. Review of Preclinical and Clinical Studies with Low Dose SKA Cytokines since 2009

Low dose oral administration of cytokines for treatment of allergic asthma

Low dose oral administration of cytokines for treatment of allergic asthma

Oral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation

Oral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation

Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study

Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study

Low Dose of IL-12 Stimulates T Cell Response in Cultures of PBMCs Derived from Non Small Cell Lung Cancer Patients

Low Dose of IL-12 Stimulates T Cell Response in Cultures of PBMCs Derived from Non Small Cell Lung Cancer Patients